Latest Conference Articles

Medication therapy management can also increase the likelihood of using statins in this population.

Four posters presented at this year’s American Pharmacists Association Annual Meeting & Exposition assessed the potential impact of pharmacist interventions on improving mental health outcomes.

According to posters presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, pharmacists wish to play a bigger role in educating young people about the risks of vaping.

Access to counseling and education were strong predictors of being dispensed contraceptives.

Results from a meta-analysis on the side of effects of the psychedelic psilocybin were presented at the 2024 American Pharmacists Association Annual Meeting & Exposition.

Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.

A panel discussion at the Outcomes 2024 SYNC National Conference touched upon many important themes in community pharmacy, including the evolving role of pharmacists, emerging tech, and key challenges going forward.

Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed during a session at Outcomes 2024 SYNC National Conference several specific opportunities at the pharmacists disposal.

Nicole Bernabe, CPhT, customer success specialist at TelePharm, discusses how the company is helping pharmacies increase operational efficiency while providing care to patients in need.

Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed how technological solutions can aid pharmacies during a session at the Outcomes 2024 SYNC National Conference in Orlando, Florida.

Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.

Advocates can amplify the voices of transgender patients as they overcome barriers to health care, said Molly Crowther in a conversation at the 2023 Healthcare Advocate Summit.

Social determinants of health (SDOH), such as financial disparities or lack of insurance, create barriers to accessing breakthrough therapies like BTK inhibitors among patients with CLL and SLL.

Three posters presented at the 65th American Society of Hematology Annual Meeting and Exposition looked into the efficacy and safety of the therapies.

Data from the Surveillance, Epidemiology, and End Results (SEER) database were reviewed.

Six posters presented at the 65th American Society of Hematology Annual Meeting and Exposition looked at how treatments are impacting care for this patient population.

Understanding the adverse event profile of bispecific antibodies can aid treatment selection and improve patient outcomes.

Results of the phase 3 PERSEUS study were presented at the 2023 ASH Annual Meeting and Exposition.

Safiya Tisdell, vice president of Adparo Services at Annexus Health, details the available assistance options designed to ease the financial burden associated with accessing care for both patients and providers.

Two posters presented at ASHP Midyear 2023 explored the impact of diabetes management interventions among patients with diabetes.

The analysis revealed deeper issues created by payer and manufacturer lockouts placed on Integrated Health System Specialty Pharmacies.

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

Investigators developed a new Plan-Do-Study-Act cycle to meet standards of USP <800> at a central-fill pharmacy.

A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.

Increased clinical awareness around the value of lithium monitoring was ultimately achieved.

A study presented at ASHP Midyear 2023 found that primary care physicians said a refill management service helped reduce burnout and improved the quality of patient care.

A Q&A with Lisa McCabe, PharmD, MBA, BSN, director of Health System Pharmacy at Cardinal Health.

Most patients were not concerned about losing control over their disease after switching.